About Ribometrix
Ribometrix is a company based in Raleigh (United States) founded in 2016.. Ribometrix has raised $65.3 million across 11 funding rounds from investors including AbbVie, ARE and Vertex Pharmaceuticals. The company has 26 employees as of December 31, 2022. Ribometrix operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Raleigh, United States
- Employees 26 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ribometrix, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65.3 M (USD)
in 11 rounds
-
Latest Funding Round
$20 M (USD), Series A
Sep 30, 2019
-
Investors
AbbVie
& 14 more
-
Employee Count
26
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Ribometrix
Ribometrix has successfully raised a total of $65.3M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series A — $20.0M
-
First Round
First Round
(01 May 2016)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Series A - Ribometrix | Valuation | Vertex Pharmaceuticals |
|
| Sep, 2019 | Amount | Series A - Ribometrix | Valuation | SV Health Investors , Illumina Ventures |
|
| Nov, 2018 | Amount | Series A - Ribometrix | Valuation | M Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ribometrix
Ribometrix has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include AbbVie, ARE and Vertex Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on early-stage healthcare startups
|
Founded Year | Domain | Location | |
|
Health tech startups are invested in by Illumina Ventures.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ribometrix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ribometrix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ribometrix Comparisons
Competitors of Ribometrix
Ribometrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ribometrix
Frequently Asked Questions about Ribometrix
When was Ribometrix founded?
Ribometrix was founded in 2016.
Where is Ribometrix located?
Ribometrix is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Is Ribometrix a funded company?
Ribometrix is a funded company, having raised a total of $65.3M across 11 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on May 01, 2016.
How many employees does Ribometrix have?
As of Dec 31, 2022, the latest employee count at Ribometrix is 26.
What does Ribometrix do?
Founded in 2016, Ribometrix operates in the biotechnology sector from Raleigh, United States. Three-dimensional structural analysis of RNA is employed to support a drug discovery platform. Novel small molecules are identified through this approach to modulate RNA function and associated proteins in human diseases. The platform focuses on therapeutic development for disease-related targets.
Who are the top competitors of Ribometrix?
Ribometrix's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Who are Ribometrix's investors?
Ribometrix has 15 investors. Key investors include AbbVie, ARE, Vertex Pharmaceuticals, HHS, and North Carolina Department of Commerce.